Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET
Status:
Recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
This randomised double-blinded controlled trial aims to compare the live birth rate in
natural FET cycles with and without oral dydrogesterone as luteal phase support. The
hypothesis is that the use of oral dydrogesterone will increase the live birth rate of
natural cycle FET.